beta
/092 Efficacy and safety of the oral Bruton’s tyrosine kinase inhibitor, remibrutinib, in patients with moderate to severe hidradenitis suppurativa in a randomized, phase 2, double-blind, placebo-controlled platform study
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Data not found

Cited By (0)